An Ohio federal judge has made a significant ruling on March 18 in the ongoing national opioid litigation by denying OptumRx's bid to disqualify the law firm Motley Rice LLC from representing plaintiffs. This decision comes amid broader discussions and controversies surrounding the opioid crisis and the legal battles it has engendered. Although the motion for disqualification was rejected, the judge issued a caution to Motley Rice, urging the plaintiffs' bar to proceed with caution. This development is seen as a victory for Motley Rice, reinforcing its position in the opioid cases despite the challenges posed by opponents such as OptumRx.
Motley Rice won a battle on March 18 when a judge denied an attempt by OptumRx to oust it from litigation arising from the opioids crisis. But the ruling gives new ammunition to critics fighting a broader policy war, writes columnist @AlisonFrankel https://t.co/9g4NFfMnTY https://t.co/mlTAF2BjjE
An Ohio federal judge has denied a bid by pharmacy benefit manager OptumRx to disqualify Motley Rice LLC from representing plaintiffs in the national opioid litigation. https://t.co/eksSqIdhxn
Plaintiffs Claim Bad Evidentiary Rulings Fueled Monsanto's First Phila. Roundup Trial Win https://t.co/ddbbyKgyUq
A judge opted not to disqualify Motley Rice from opioid cases, but he urged the plaintiffs bar to proceed with caution: https://t.co/W20e7V5U9g
Opioid Judge Rejects DQ Motion But Cautions Motley Rice: 'The Court Frowns' https://t.co/ACEd3vfd0n